These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 8259475)
1. [Effect of ciprofloxacin therapy in duration of bacterial excretion in acute salmonella gastroenteritis]. Funke G; Nemes P; Lüthy-Hottenstein J; Altwegg M Schweiz Med Wochenschr; 1993 Oct; 123(41):1935-40. PubMed ID: 8259475 [TBL] [Abstract][Full Text] [Related]
2. [Experience with ciprofloxacin therapy of salmonellosis gastroenteritica]. Bíró L; Rókusz L; Szepesi A; Várszegi J Orv Hetil; 1992 Jan; 133(4):215-6, 221. PubMed ID: 1736229 [TBL] [Abstract][Full Text] [Related]
3. [No floroquinolone resistance in non typhoidal salmonellas from hospitalized persons in an endemic area of Apulia, Italy]. Rollo MA; Buccoliero G; Lonero G; Romanelli C; Loperfido P; Cristiano L; Chimienti A; Angelini P; Resta F Recenti Prog Med; 2004 Sep; 95(9):414-7. PubMed ID: 15473379 [TBL] [Abstract][Full Text] [Related]
5. Treatment of Salmonella gastroenteritis with ampicillin, amoxicillin, or placebo. Nelson JD; Kusmiesz H; Jackson LH; Woodman E Pediatrics; 1980 Jun; 65(6):1125-30. PubMed ID: 7375236 [TBL] [Abstract][Full Text] [Related]
6. [Bacillus subtilis IP 5832 (Flonivin BS) shortens the duration of the carrier state in patients with acute non-typhoid salmonella enteritis]. Vuković M Med Pregl; 2001; 54(1-2):62-8. PubMed ID: 11432326 [TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy of ciprofloxacin compared with placebo in bacterial diarrhea. Pichler HE; Diridl G; Stickler K; Wolf D Am J Med; 1987 Apr; 82(4A):329-32. PubMed ID: 3555057 [TBL] [Abstract][Full Text] [Related]
8. [Treatment of salmonellosis and shigellosis with the new quinolones]. Biron F; Boibieux A; Tigaud S; Peyramond D Pathol Biol (Paris); 1990 Nov; 38(9):894-8. PubMed ID: 2277722 [TBL] [Abstract][Full Text] [Related]
9. Influence of ciprofloxacin resistance on risk factors for endovascular infection in patients with infection due to group C nontyphoid salmonellae. Hsu RB; Chen RJ; Lin FY; Chu SH Clin Infect Dis; 2005 May; 40(9):1364-7. PubMed ID: 15825041 [TBL] [Abstract][Full Text] [Related]
10. [Ciprofloxacin in Salmonella infection and abdominal typhoid]. Klein E; Trautmann M; Hoffmann HG Dtsch Med Wochenschr; 1986 Oct; 111(42):1599-602. PubMed ID: 3769803 [TBL] [Abstract][Full Text] [Related]
11. Cefotaxime-ciprofloxacin combination therapy for nontyphoid Salmonella bacteremia and paravertebral abscess after failure of monotherapy. Chang CM; Lee HC; Lee NY; Huang GC; Lee IW; Ko WC Pharmacotherapy; 2006 Nov; 26(11):1671-4. PubMed ID: 17064216 [TBL] [Abstract][Full Text] [Related]
12. Salmonella excretion after cessation of tosufloxacin therapy in acute nontyphoid salmonella enterocolitis. Ohnishi K; Kimura K Antimicrob Agents Chemother; 2001 Jun; 45(6):1892-3. PubMed ID: 11353646 [TBL] [Abstract][Full Text] [Related]
13. Antimicrobial drug resistance in salmonella-infected aortic aneurysms. Hsu RB; Lin FY; Chen RJ; Hsueh PR; Wang SS Ann Thorac Surg; 2005 Aug; 80(2):530-6. PubMed ID: 16039199 [TBL] [Abstract][Full Text] [Related]
14. Epicillin in the treatment of shigellosis and salmonellosis. Landa L Curr Ther Res Clin Exp; 1971 Oct; 13(10):654-9. PubMed ID: 4338475 [No Abstract] [Full Text] [Related]
15. [Therapy of salmonella gastroenterocolitis]. Brkić S; Knezević K; Celanović M; Jovanović J; Madle-Samardzija N Med Pregl; 1994; 47(9-10):353-7. PubMed ID: 7565327 [TBL] [Abstract][Full Text] [Related]
16. [Extra-intestinal infections caused by non-typhi Salmonella serotypes. 9 yrs' experience]. Ruiz M; Rodríguez JC; Elía M; Royo G Enferm Infecc Microbiol Clin; 2000 May; 18(5):219-22. PubMed ID: 10974765 [TBL] [Abstract][Full Text] [Related]
17. [Epidemiological profile of non-typhi salmonellosis in a hospital in urban Madrid (1980-1994)]. Ramos JM; Cuenca-Estrella M; Alés JM; Soriano F Enferm Infecc Microbiol Clin; 1996; 14(6):345-51. PubMed ID: 8756211 [TBL] [Abstract][Full Text] [Related]